OpenClinica Hosts Global Conference in Boston

Share Article

May 8-9 Event Features Ken Getz as Keynote Speaker

We are thrilled to have Mr. Getz share his vision for biopharmaceutical innovation

Waltham, MA On May 8-9, medical researchers and technologists from around the globe will convene at the second annual OpenClinica Global Conference in Boston. The event is being held at the Metro Meeting Centers at101 Federal Street. OpenClinica is a worldwide leader in providing open source software for clinical trials and is raising the standards for efficiency and transparency in clinical research worldwide while enabling the development of new medical treatments by lowering the cost of clinical trials.

The OpenClinica Global Conference brings together users, developers, and other stakeholders from the OpenClinica community to share knowledge and best practices. The event features lectures, case studies, tutorials, panel discussions, posters, and technical demonstrations. Participants in the event represent numerous countries including, China, Brazil, India, Denmark, Taiwan, Switzerland, and the United Kingdom.

Kenneth A. Getz, noted industry thought leader, Chairman of the Center for Information & Study on Clinical Research Participation CISCRP, and Senior Research Fellow and Assistant Research Professor at the Tufts Center for the Study of Drug Development, will be the conference’s keynote speaker.

“We are thrilled to have Mr. Getz share his vision for biopharmaceutical innovation,” said Cal Collins, OpenClinica Chief Executive. “His forward thinking addresses many of the critical challenges that must be overcome in clinical research.”

Mr. Getz’s keynote presentation, titled Driving Biopharmaceutical Innovation through Integrated and Open Communities, builds on his unique perspective as a recognized authority on drug development best practices and innovation. “The sustainability of drug development desperately depends on new models of innovation,” said Mr. Getz. “Innovative open source projects like OpenClinica hold tremendous promise for addressing this need.”

Ben Baumann, OpenClinica’s Director of Business Development, says attendees will also get to experience demonstrations of OpenClinica 3.1 which is expected to be formally released at the conference.

“Early reactions indicate that clinical sponsors, CROs, and academic groups in both the U.S. and abroad will be pleased with how OpenClinica 3.1 further streamlines electronic data capture in clinical trials,” said Baumann.

  • Sessions planned for this year’s Conference include:
  • Using OpenClinica for Patient Reported Data for Risk Screening Studies
  • OpenClinica and Clinical Trials in China
  • Implementation and Rollout of OpenClinica at Oxford, UK
  • OpenClinica as the Electronic Database of the Brazilian Network of Studies on Reproductive and Perinatal Health

OpenClinica will also provide hands-on training at the Conference and discussions covering how open source can facilitate leading edge e-clinical objectives such as integration of clinical trial electronic data capture (EDC) and electronic medical records (EMR).

Because of its commercial open source licensing model, OpenClinica stands alone as the most flexible, cost effective solution for EDC and clinical data management. The commercial version, OpenClinica Enterprise, offers advanced capabilities, regulatory compliance, and support for mission critical operations.
Several hundred health science organizations worldwide use the OpenClinica software to power their clinical trials. The community of OpenClinica users, developers and practitioners now exceeds 12,000.
Registration for the Conference is now open. Click here to complete a registration form.

About OpenClinica®

OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information – including product downloads – visit or follow @OpenClinica on Twitter.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matt Ellis
(617) 278-6560
Email >
Visit website